Design and Evaluation of an Ontology-based Drug Application Database

Summary

Objectives: Several recently published cases of preventable adverse drug reactions were associated with flaws in drug application. However, current clinical decision support (CDS) systems do not properly consider drug application issues and thus do not support effective prevention of such medication errors. With the aim to improve CDS in this respect, we developed a comprehensive model precisely describing all aspects of drug application.

Methods: The model consists of 1) a schema comprising all relevant attributes of drug application and 2) an ontology providing a hierarchically structured vocabulary of terms that describe the possible values of the schema’s attributes. Finally, medical products were annotated by a semi-automatic term assignment process. For evaluation, we developed an algorithm that uses our model to compute a meaningful similarity between medicinal products with respect to their drug application characteristics.

Results: Our schema consists of 22 attributes. The ontology contains 248 terms, textual descriptions, and synonym lists. More than 58,700 medicinal products were automatically annotated with >386,600 terms. 2450 drugs were manually reviewed by experts, adding > 4500 terms. The annotation and similarity measure allow for (similarity) searches, clustering, and proper discrimination of drugs with different drug application characteristics. We demonstrated the value of our approach by means of a set of case studies.

Conclusion: Our model enables a detailed description of drug application, allowing for semantically meaningful comparisons of drugs. This is an important prerequisite for improving the ability of CDS systems to prevent prescription errors.

Keywords

Drug information system - ontology - drug administration - electronic decision support

^* Both authors contributed equally to the work.

• References

• 1 Kaushal R, Shojania KG, Bates DW. Effects of computerized physician order entry and clinical decision support systems on medication safety. A systematic review. Arch Intern Med 2003; 163: 1409-1416.
• 2 Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: A systematic review of trials to identify features critical to success. BMJ 2005; 330: 765-772.
• 3 van der Sijs H, Aarts J, Vulto A, Berg M. Overriding of drug safety alerts in computerized physician order entry. J Am Med Inform Assoc 2006; 13: 138-147.
• 4 Mohr JF, Hall AC, Ericsson CD, Ostrosky-Zeichner L. Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation. Pharmacotherapy 2005; 25: 426-428.
• 5 Burke D, Lal R, Finkel KW, Samuels J, Foringer JR. Acute amphotericin B overdose. Ann Pharmacother 2006; 40: 2254-2259.
• 6 Neuhofel AL, Wilton JH, Victory JM, Hejmanowsk LG, Amsden GW. Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction. J Clin Pharmacol 2002; 42: 461-466.
• 7 Payne TH, Nichol P, Hoey P, Savarino J. Characteristics and override rates of order checks in a practitioner order entry system. Amia Symp Proc. 2002 pp 602-606.
• 8 Dettmeyer R, Driever F, Becker A, Wiestler OD, Madea B. Fatal myeloencephalopathy due to accidental intrathecal vincristin administration: a report of two cases. Forensic Sci Int 2001; 122: 60-64.
• 9 Walk SU, Bertsche T, Kaltschmidt J, Pruszydlo MG, Hoppe-Tichy T, Walter-Sack I. et al. Rule-based standardised switching of drugs at the interface between primary and tertiary care. Eur J Clin Pharmacol 2008; 64: 319-327.
• 10 Andersson KA, Petzold MG, Allebeck P, Carlsten A. Influence of mandatory generic substitution on pharmaceutical sales patterns: a national study over five years. BMC Health Serv Res 2008; 8: 50.
• 11 Kawazoe Y, Ohe K. An ontology-based mediator of clinical information for decision support systems: a prototype of a clinical alert system for prescription.
• 12 The Gene Ontology Consortium.. Creating the gene ontology resource: design and implementation. Genome Research 2001; 11: 1425-1433.
• 13 Liu JH, Milstein C, Séné B, Venot A. Object-oriented modeling and terminologies for drug contraindications. Methods Inf Med 1998; 37: 45-52.
• 14 Cimino JJ. The concepts of language and the language of concepts. Methods Inf Med 1998; 37: 311.
• 15 Alexa A, Rahnenfuhrer J, Lengauer T. Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics 2006; 22: 1600-1607.
• 16 Popescu M, Arthur G. OntoQuest: A physician decision support system based on ontological queries of the hospital database. Amia Symp Proc 2006: 639.
• 17 Jiang JJ, Conrath DW. Semantic similarity based on corpus statistics and lexical taxonomy. Proceedings of International Conference Research on Computational Linguistics (ROCLING X). 1997
• 18 Bodenreider O. Biomedical ontologies in action: role in knowledge management, data integration and decision support. Yearb Med Inform 2008 pp 67-79.
• 19 Bodenreider O. The Unified Medical Language System (UMLS): integrating biomedical terminology. Nuc Acids Res 2004; 32: 267-270.
• 20 Khan AN, Griffith SP, Moore C, Russell D, Rosario Jr AC, Bertolli J. Standardizing laboratory data by mapping to LOINC. J Am Med Inform Assoc 2006; 13: 353-355.
• 21 International Health Terminology Standards Development Organisation (IHTSDO).. Systematised Nomenclature of Medicine – Clinical Terms (SNOMED CT). http://www.ihtsdo.org. Accessed March 24, 2010
• 22 Lui S, Ma W, Moore R, Ganesan V, Nelson S. RxNorm: Prescription for electronic drug information exchange. IT Professional 2005; 7: 17-23.
• 23 Solomon WD, Wroe CJ, Rector AL, Rogers JE, Fistein JL, Johnson P. A reference terminology for drugs. Proc AMIA Symp 1999 pp 152-155.
• 24 ABDATA – Pharma-Daten-Service.. Abda-Artikelstamm. Available from: http://www.wuv-gmbh.de/de/pages/abdata/artikelstamm.php. Accessed March 27, 2010
• 25 FDA, CDER.. Data standards manual for routes of administration. Available at: http://www.fda.gov/cder/dsm/DRG/drg00301.htm. Accessed December 4, 2008
• 26 Council of Europe.. The European Pharmacopoeia, 6th ed. 2007
• 27 Council of Europe.. Standard Terms. Pharmaceutical dosage forms. Routes of administration. Containers. European Directorate for the Quality of Medicines, 5th ed. 2004
• 28 Medizinische Medien Informations GmbH MMI. Gelbe Liste Pharmindex. Available from: http://www.gelbe-liste.de. Accessed March 27, 2010
• 29 Ganesan P, Garcia-Molina H, Widom J. Exploiting hierarchical domain structure to compute similarity. ACM Transitions on Information Systems 2003; 21: 64-93.
• 30 Kuperman GJ, Bobb A, Payne TH, Avery AJ, Gandhi TK, Burns G, Classen DC, Bates DW. Medication-related clinical decision support in computerized provider order entry systems: a review. J Am Med Inform Assoc 2007; 14: 29-40.
• 31 Sittig DF, Wright A, Osheroff JA, Middleton B, Teich JM, Ash JS, Campbell E, Bates DW. Grand challenges in clinical decision support. J Biomed Inform 2008; 41: 387-392.
• 32 Seidling HM, Schmitt SPW, Bruckner T, Kaltschmidt J, Pruszydlo MG, Senger C, Bertsche T, Walter-Sack I, Haefeli WE. Patient-specific electronic decision support reduces prescription of excessive doses. Qual Saf Health Care; 2010. (in press).
• 33 Marder VJ. The use of thrombolytic agents: choice of patient, drug administration, laboratory monitoring. Ann Intern Med 1979; 90: 802-808.
• 34 Quinzler R, Gasse C, Schneider A, Kaufmann-Kolle P, Szecsenyi J, Haefeli WE. The frequency of inappropriate tablet splitting in primary care. Eur J Clin Pharmacol 2006; 62: 1065-1073.